These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9790069)

  • 1. Establishment of monoclonal antibody, gp21-34, against HTLV-II envelope protein (p20E).
    Miyagawa E; Yoshiki A; Fujii N; Honda H; Ueno E; Kurano Y; Ito S
    Hybridoma; 1998 Aug; 17(4):347-54. PubMed ID: 9790069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
    Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
    Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
    Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel monoclonal antibody specifically reactive with human T-lymphotropic virus type-II (HTLV-II) envelope protein.
    Ohara N; Hayashi K; Takahashi K; Miyamoto K; Akagi T
    Int J Cancer; 1993 Jul; 54(5):858-61. PubMed ID: 8325711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
    J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
    J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping of human monoclonal antibodies recognizing conformational epitopes within HTLV type 1 gp46, employing HTLV type 1/2 envelope chimeras.
    Hadlock KG; Yang Q; Rowe J; Foung SK
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):57-70. PubMed ID: 11804557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
    Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
    Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel neutralization epitope on envelope gp46 antigen of human T-cell-leukemia virus-type-II (HTLV-II).
    Tanaka Y; Tanaka R; Hoshino H
    Int J Cancer; 1994 Dec; 59(5):655-60. PubMed ID: 7525496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HTLV-I envelope protein fused to hydrophobic amino-terminal peptide of baculovirus polyhedrin in insect cells and its application for serological assays.
    Nyunoya H; Ogura T; Kikuchi M; Iwamoto H; Yamashita K; Maekawa M; Takebe Y; Miyamura K; Yamazaki S; Shimotohno K
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1311-21. PubMed ID: 2078412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.
    Chen YM; Zhang XQ; Dahl CE; Samuel KP; Schooley RT; Essex M; Papas TS
    J Immunol; 1991 Oct; 147(7):2368-76. PubMed ID: 1717557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.
    Lal RB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S170-8. PubMed ID: 8797720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
    Lal RB; Rudolph DL; Kaplan JE; Hjelle B; Levine PH; Coligan JE; Viscidi RP
    Virology; 1992 Jan; 186(1):274-9. PubMed ID: 1727602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human T-lymphotropic virus type-I/II env antibodies by immunoassays using recombinant fusion proteins.
    Rudolph DL; Khabbaz RF; Folks TM; Lal RB
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):35-9. PubMed ID: 8102953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
    Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I.
    Edouard E; Legrand E; Astier-Gin T; Dalibart R; Geoffre S; Dalbon P; Guillemain B; Londos-Gagliardi D
    Leukemia; 1994 Apr; 8 Suppl 1():S60-4. PubMed ID: 7512182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
    Hadlock KG; Rowe J; Perkins S; Bradshaw P; Song GY; Cheng C; Yang J; Gascon R; Halmos J; Rehman SM; McGrath MS; Foung SK
    J Virol; 1997 Aug; 71(8):5828-40. PubMed ID: 9223472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.